​

Taysha Gene Therapies (TSHA) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Taysha Gene Therapies Revenue Highlights

Latest Revenue (Y)

$8.33M

Latest Revenue (Q)

$1.79M

Taysha Gene Therapies Revenue by Period

Taysha Gene Therapies Revenue by Year

DateRevenueChange
2024-12-31$8.33M-46.07%
2023-12-31$15.45M517.55%
2022-12-31$2.50M100.00%
2021-12-31-100.00%
2020-12-31-100.00%
2019-12-31--

Taysha Gene Therapies generated $8.33M in revenue during NA 2024, up -46.07% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Taysha Gene Therapies Revenue by Quarter

DateRevenueChange
2024-09-30$1.79M60.79%
2024-06-30$1.11M-67.40%
2024-03-31$3.41M-5.36%
2023-12-31$3.60M-24.06%
2023-09-30$4.75M98.16%
2023-06-30$2.40M-49.11%
2023-03-31$4.71M88.09%
2022-12-31$2.50M100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31--

Taysha Gene Therapies generated $1.79M in revenue during Q3 2024, up 60.79% compared to the previous quarter, and up 74.66% compared to the same period a year ago.

Taysha Gene Therapies Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
DAWNDay One Biopharmaceuticals$131.16M$20.07M
GOSSGossamer Bio$114.70M$9.48M
ALECAlector$100.56M$15.08M
GLUEMonte Rosa Therapeutics$75.62M$4.70M
STOKStoke Therapeutics$36.55M$4.89M
CCCCC4 Therapeutics$20.76M-
TSHATaysha Gene Therapies$8.33M$1.79M
STTKShattuck Labs$5.72M$1.61M
XFORX4 Pharmaceuticals$2.56M$560.00K
AKROAkero Therapeutics--
CABACabaletta Bio--
PRLDPrelude Therapeutics--
INZYInozyme Pharma--
TERNTerns Pharmaceuticals--
HOOKHOOKIPA Pharma-$4.70M
BMEABiomea Fusion--
LRMRLarimar Therapeutics--

TSHA Revenue FAQ

What is Taysha Gene Therapies’s yearly revenue?

Taysha Gene Therapies's yearly revenue for 2024 was $8.33M, representing a decrease of -46.07% compared to 2023. The company's yearly revenue for 2023 was $15.45M, representing an increase of 517.55% compared to 2022. TSHA's yearly revenue for 2022 was $2.5M, representing an increase of 100.00% compared to 2021.

What is Taysha Gene Therapies’s quarterly revenue?

Taysha Gene Therapies's quarterly revenue for Q3 2024 was $1.79M, a 60.79% increase from the previous quarter (Q2 2024), and a -62.33% decrease year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $1.11M, a -67.40% decrease from the previous quarter (Q1 2024), and a -53.57% decrease year-over-year (Q2 2023). TSHA's quarterly revenue for Q1 2024 was $3.41M, a -5.36% decrease from the previous quarter (Q4 2023), and a -27.52% decrease year-over-year (Q1 2023).

What is Taysha Gene Therapies’s revenue growth rate?

Taysha Gene Therapies's revenue growth rate for the last 3 years (2022-2024) was 233.05%, and for the last 5 years (2020-2024) was 0%.